Evaluating incidence, prevalence, and treatment trends in adult men with hypogonadism in the United States
- 29 November 2021
- journal article
- research article
- Published by Springer Nature in International Journal Of Impotence Research
- Vol. 34 (8) , 762-768
Abstract
No extensive studies have investigated current diagnosis and treatment trends of hypogonadism (HG) in adult men in the United States. Using a comprehensive commercial insurance database, we surveyed current trends in incidence, prevalence, and treatment of hypogonadism in the United States. We analyzed insurance claims data from 2008–2017 using the IBM MarketScan™ Commercial Claims and Encounters database for men ≥18. Overall, we estimated annual incidence at 16.1 cases per 100,000 person-years, with the highest incidence seen among men 35–44 years at 21.5 cases per 100,000 person-years (IRR 1.83; 95% CI 1.63, 2.06, p < 0.001) and among those living in the Southern United States at 22.6 cases per 100,000 person-years (IRR 1.96; 95% CI 1.76, 2.18, p < 0.001). The prevalence of HG across the study period increased from 0.78% to 5.4%, while treatment rates decreased from 32.9% to 20.8%. These study findings provide a large-scale view of current diagnosis rates and treatment of hypogonadism in adult men in the United States. Despite the increase in prevalence of disease, there is an observed decline in treatment rates after diagnosis. Further investigations are needed to identify factors driving the observed decline in healthcare utilization among men with hypogonadism.Keywords
This publication has 12 references indexed in Scilit:
- Trends in Testosterone Replacement Therapy Use from 2003 to 2013 among Reproductive-Age Men in the United StatesJournal of Urology, 2017
- Testosterone and “Age-Related Hypogonadism” — FDA ConcernsNew England Journal of Medicine, 2015
- Regional disparities in obesity prevalence in the United States: A spatial regime analysisObesity, 2014
- Patient Satisfaction with Testosterone Replacement Therapies: The Reasons Behind the ChoicesThe Journal of Sexual Medicine, 2014
- The long‐term efficacy and safety of a testosterone mucoadhesive buccal tablet in testosterone‐deficient menBJU International, 2012
- Characteristics of Secondary, Primary, and Compensated Hypogonadism in Aging Men: Evidence from the European Male Ageing StudyThe Journal of Clinical Endocrinology & Metabolism, 2010
- Changes in Muscle Mass, Muscle Strength, and Power but Not Physical Function Are Related to Testosterone Dose in Healthy Older MenJournal of the American Geriatrics Society, 2008
- Correlates of Low Testosterone and Symptomatic Androgen Deficiency in a Population-Based SampleThe Journal of Clinical Endocrinology & Metabolism, 2008
- Hypothalamic-Pituitary-Testicular Axis Disruptions in Older Men Are Differentially Linked to Age and Modifiable Risk Factors: The European Male Aging StudyThe Journal of Clinical Endocrinology & Metabolism, 2008
- Prevalence of Symptomatic Androgen Deficiency in MenThe Journal of Clinical Endocrinology & Metabolism, 2007